Literature DB >> 11596107

Dynamic changes in p27kip1 variant expression in activated lymphocytes.

B Yaroslavskiy1, S C Watkins, S Alber, R A Steinman.   

Abstract

The p27Kip1 cell cycle inhibitor (p27) has emerged as a critical mediator of normal cellular growth control. We report the expression of a 24 kD C-terminal variant of p27 in normal peripheral blood lymphocytes. This variant is rapidly degraded in a proteasome-dependent manner when lymphocytes are activated by interleukin-2 or by superantigen. Whereas p24 degradation is complete within 16 h of mitogen addition, full-length p27 is decreased only modestly over 72 h of mitogen exposure and is present in activated and cycling lymphocytes. Persistent p27 is present in a complex with cyclin D3 in activated lymphocytes, and is localized both in the nucleus and cytoplasm. These results indicate that lymphocytes exiting from quiescence use several mechanisms to overcome the p27Kip1-enforced cell cycle checkpoint, and that elimination of p27 is not required for cell cycle entry. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11596107     DOI: 10.1002/jcb.1243

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  1 in total

1.  yuDetecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients.

Authors:  William Humphries; Yongtao Wang; Wei Qiao; Chantal Reina-Ortiz; Mohamed K Abou-Ghazal; Lamonne M Crutcher; Jun Wei; Ling-Yuan Kong; Raymond Sawaya; Ganesh Rao; Jeffrey Weinberg; Sujit S Prabhu; Gregory N Fuller; Amy B Heimberger
Journal:  J Transl Med       Date:  2009-11-09       Impact factor: 5.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.